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Abstract
Background: Bone marrow derived mesenchymal stem cells (MSCs) are promising candidates for cell based therapies 
in myocardial infarction. However, the exact underlying cellular mechanisms are still not fully understood. Our aim was 
to explore the possible role of direct cell-to-cell interaction between ischemic H9c2 cardiomyoblasts and normal MSCs. 
Using an in vitro ischemia model of 150 minutes of oxygen glucose deprivation we investigated cell viability and cell 
interactions with confocal microscopy and flow cytometry.
Results: Our model revealed that adding normal MSCs to the ischemic cell population significantly decreased the ratio 
of dead H9c2 cells (H9c2 only: 0.85 ± 0.086 vs. H9c2+MSCs: 0.16 ± 0.035). This effect was dependent on direct cell-to-
cell contact since co-cultivation with MSCs cultured in cell inserts did not exert the same beneficial effect (ratio of dead 
H9c2 cells: 0.90 ± 0.055). Confocal microscopy revealed that cardiomyoblasts and MSCs frequently formed 200-500 nm 
wide intercellular connections and cell fusion rarely occurred between these cells.
Conclusion: Based on these results we hypothesize that mesenchymal stem cells may reduce the number of dead 
cardiomyoblasts after ischemic damage via direct cell-to-cell interactions and intercellular tubular connections may 
play an important role in these processes.
Background
Cardiovascular diseases represent an enormous medical
and social burden [1,2] and the pathophysiology of most
of these diseases, such as myocardial infarction or heart
failure, involves death of cardiac myocytes leading to a
loss of functional tissue. Cell based therapies are com-
monly believed to be the next generation of therapies for
replacing such lost tissue [3-5]. Several in vivo animal and
human studies have found that implantation of various
cell types, typically bone marrow derived stem cells, into
damaged myocardium improved cardiac performance.
Also where the experimental protocol allowed, surviving
grafted cells were detected in the myocardium [6,7], sug-
gesting that grafting is an effective treatment of acute
myocardial infarction [8]. However, the extent of the ben-
eficial effect, the optimal cell type and number, the best
method of administration, and the mechanism of action
need to be further evaluated [9].
One important issue is the exact mechanism of action,
in other words, the interaction between graft and host.
Paracrine factors, transdifferentiation and cell fusion are
the three generally accepted hypotheses explaining the
beneficial effects of stem cell grafting. Paracrine factors
through various effects, such as increased angiogenesis or
modulation of postinfarct remodeling, may represent an
important aspect of the benefits [10,11]. On the other
hand, several studies have found that co-culture of cardi-
omyocytes with pluripotent stem cells resulted in trans-
differentiation of these cells into cardiomyocytes, which
raised the hope that in vitro cultured tissue blocks can
later be used for cardiac repair [12,13]. However,
although it is possible to construct a tissue in vitro this
does not mean that its building blocks will perform simi-
larly when implanted in vivo [14]. Indeed, recent investi-
gations found difficult to reproduce transdifferentiation
and that bone marrow derived cells generate cardiomyo-
cytes not by transdifferentiation but rather through cell
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fusion [15,16]. Alvarez-Dolado et al demonstrated that
bone marrow derived cells fused with cardiomyocytes
[17], but the importance of cell fusion events was ques-
tioned by an other investigation [18]. Even in studies
which found morphologically adequate new cardiomyo-
cytes, the volume of this newly formed tissue seemed to
be inadequate to account for the functional benefits.
Other hypotheses have also emerged to resolve the
apparent controversy among the clinical findings and the
cell culture studies, such as the most recently proposed
partial cell fusion through direct cell-to-cell interactions.
This novel intercellular communication route depends on
short cell-to-cell interactions, during which the two con-
nected cells exchange membrane and organelle parts
such as mitochondria or other cytoplasmatic compo-
nents [19]. Recently, it was reported that cardiomyocytes
and human mesenchymal stem cells appear to communi-
cate through small diameter nanotubes, and mitochon-
d r i a  c a n  m i g r a t e  f r o m  M S C s  t o  c a r d i o m y o c y t e s  [ 2 0 ] .
However, the physiological purpose of this constantly
changing nanotubular network and its possible role dur-
ing ischemic conditions is unclear. We hypothesized that
stem cells and post-ischemic cardiomyoblasts interact
with each other via this novel mechanism and that this
mechanism may play a role in the beneficial effect of stem
cell transplantation.
The aim of our study was to examine the possibility of
rescuing ischemically damaged H9c2 cardiomyoblasts
from cell death by adding mesenchymal stem cells to the
cultures after ischemia. Furthermore we investigated the
importance of direct cell-to-cell interactions during co-
cultivation of these cells.
Methods
Isolation and culture of cardiomyoblasts and MSCs
H9c2 rat cardiomyoblasts were obtained from ATCC
(Wesel, Germany) and expanded in high glucose (4.5 g/L)
DMEM containing 10% fetal bovine serum, 4 mM L-glu-
tamine, 100 U/ml penicillin and 100 μg/ml streptomycin.
Mouse mesenchymal stem cells (MSCs) were harvested
from the femur of C57Bl/6 mice. Isolation and primary
culture was performed according to Tropel's method with
small alterations [21]. Briefly, animals were anaesthetized
with pentobarbital (ip, 50 mg/kg, Nembutal, Ovation,
Deerfield, IL, USA), lower limbs were removed and
femurs were cleaned of tissue. Bone marrow was col-
lected by flushing femurs with low glucose DMEM con-
taining 10% fetal bovine serum, 2 mM L-glutamine, 100
U/ml penicillin and 100 μg/ml streptomycin. Cells were
centrifuged at 1200 rpm and plated in a T75 flask. After
4-5 days, non-adherent cells were removed by washing
twice with PBS and adherent cells were then cultured in
low glucose DMEM complete medium. Characterization
o f  t h e  c u l t u r e d  M S C s  s h o w e d  t h a t  t h e s e  c e l l s  w e r e
strongly positive for the specific surface antigen Sca-1
and negative for differentiation markers of other cell lin-
eages (CD34, CD3ε, CD45R/B220, CD11b, 6G, and TER-
119) and were able to differentiate into the osteoblast and
adipocyte lineages in vitro, verifying the MSC phenotype
[22]. Cell culture media was replaced every 2-3 days
thereafter. All investigations conformed to the Guide for
the Care and Use of Laboratory Animals published by the
National Institutes of Health (NIH Publication No. 85-23,
Revised 1985), and were approved by the local ethics
committee.
In vitro ischemia model
Ischemia-reperfusion was simulated in vitro by perform-
ing oxygen glucose deprivation (OGD) on H9c2 cell cul-
tures. Cells were incubated in glucose-free DMEM in an
atmosphere of 0.5% O2 and 99.5% N2 for 150 minutes.
This procedure was performed on the stage of the confo-
cal microscope (PECON incubation system, Erbach-
Bach, Germany) allowing the observation of the cells dur-
ing OGD. T o evaluate cell viability we used calcein-AM
(excitation/emission 494/517 nm) to identify live cells,
and ethidium-homodimer (excitation/emission 528/617
nm) to stain dead or damaged cells [23].
Co-cultivation of cardiomyoblasts and MSCs after OGD
H9c2 cells and MSCs were labeled before co-cultivation
with Vybrant DiO (excitation/emission: 488/501 nm) and
DiD (excitation/emission: 633/665 nm) (Molecular
Probes, USA) membrane dyes in a dilution of 1:200
according to the manufacturer's description for 30 min-
utes at 37°C. The DiO-labeled H9c2 cells were plated in
12 well-plates at a density of 30,000 cells/well in 2 ml cul-
ture medium. Cells were subjected to 150 min OGD, then
the medium was changed and 20,000 DiD-labeled MSCs/
well were added to the damaged H9c2 cells 30 minutes
after the end of OGD either directly or in cell culture
inserts (0.4 μm pore size, Becton Dickinson, NJ, USA).
H9c2 cells not receiving MSCs after OGD were used as
controls. Cells were cultivated for a further 24 hours,
then labeled with the dead cell stain ethidium homodi-
mer (4 μM, 30 minutes, and 37°C), then investigated
either with confocal microscopy (Zeiss LSM 510 META,
Carl Zeiss, Jena, Germany) or with flow cytometry (BD
FACSCalibur™, Becton Dickinson, NJ, USA).
Confocal microscopy and flow cytometry
Time lapse video microscopy was performed during and
after in vitro ischemia to investigate morphological
changes and possible interactions among the cells over
time (1 picture/3 minutes). The H9c2 cardiomyoblasts
and MSCs were co-cultured on 42 mm coverslips and
stained with Vybrant DiO and DiD, respectively. In
experiments to observe mitochondria, all cells wereCselenyák et al. BMC Cell Biology 2010, 11:29
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stained after OGD with MitoTracker Red (Molecular
Probes, USA) in a dilution of 1:2000 for 10 minutes at
37°C according to the manufacturer's description. Flow
cytometric measurements were performed on single cell
suspensions of trypsinized (0.05% trypsin-EDTA) cell
cultures 24 hours after OGD and on normal cell cultures
(control) using BD FACSCalibur™. DiO-labeled H9c2
cells were identified and gated. Fluorescence data were
collected using logarithmic amplification until 10,000
counts were reached.
Evaluation of fluorescence images and statistical analysis
The evaluation of confocal images for live and dead cells
selected by morphology and fluorescence was performed
w i t h  I m a g e J  s o f t w a r e  ( N a t i o n a l  I n s t i t u t e s  o f  H e a l t h ,
USA). In case of co-cultures, MSCs were distinguished
from H9c2 cells due to their Vybrant DiD cell labeling.
The ratio of dead cells was evaluated in 4 independent
fields of view (objective 10×) for each culture in a blind
fashion. The evaluation of flow cytometry files was car-
ried out using BD CellQuest™ Pro (Becton Dickinson, NJ,
USA). Statistical analysis of data was carried out using
one-way analysis of variance with Tukey's multiple com-
parison post hoc test. Data are expressed as mean ± SEM.
Results
In vitro ischemia model
The optimal duration of OGD to induce cell damage was
150 minutes (Figure 1A and additional file 1:
video1.mov). This result is based on microscopic obser-
vations of morphological changes in the cell shape and on
ethidium homodimer staining which determined
whether a particular cell was dying. Flow cytometric
analysis was also used to determine that the selected time
interval was sufficient to injure the majority of the cardio-
myoblasts (Figure 1B).
Experiments showed that 4-6 hours was not adequate
for the added MSCs to attach to the surface of the 12-well
plates and exert their effect, 48 hours produced a culture
overgrown by cardiomyoblasts and MSCs (data not
shown). Therefore, the time point for microscopic evalu-
ation and flow cytometry analysis subsequent to addition
to MSCs was determined to be 24 hours.
Co-cultivation of cardiomyoblasts and MSCs after OGD
Confocal microscopy showed that cardiomyoblasts cul-
tured alone displayed the same rounded and blebbed
morphology immediately following as well as 24 hours
after OGD (Figure 2A). Flow cytometry analysis showed
that OGD significantly increased the cell death rate in
this group as shown by the enhanced ethidium homodi-
mer fluorescence intensity (median fluorescence from 19
to 65 units, Figure 2B). Figure 2B also shows that a por-
tion of cells remained unstained with ethidium homodi-
mer even after 150 minutes due to the variability of the
model. When MSCs were added to post-ischemic cardio-
myoblasts, the morphology of the damaged cells was sim-
ilar to cells cultured in normal conditions without OGD
( F i g u r e  2 C ) .  I n  t h i s  g r o u p ,  f l o w  c y t o m e t r y  a n a l y s i s
revealed that the deleterious results of ischemia were
decreased (median fluorescence 24 versus 23 units, Fig-
ure 2D). To quantify the effect of added MSCs, confocal
images were used. This approach revealed that the ratio
of dead H9c2 cells to all H9c2 cells in the wells 24 hours
after OGD was significantly higher when the cardiomyo-
blasts were cultured alone compared to when healthy
MSCs were added to the cultures 30 minutes after OGD
(0.85 ± 0.086 vs. 0.16 ± 0.035, respectively, p < 0.05, n =
5). MSCs added in cell culture inserts, which physically
separate the two cell populations growing in the same
medium, failed to decrease the ratio of dead cells (0.90 ±
0.055, n = 5), indicating that the rescue factor is less likely
to be a soluble one and direct cell-to-cell contact may be
required (Figure 3A and 3B). The absolute number of live
H9c2 cells before and after OGD and the number of
added MSCs after OGD was also investigated. Before
OGD H9c2 cells were close to confluence (63,120 ±
7,694) and there was little increase in cell numbers during
the next 24 hours if the cells were left to grow without
OGD (76,116 ± 3,396). The number of viable cells 24
hours after OGD was very low when cultured alone or
with MSCs in cell insert (1,757 ± 1,081 and 990 ± 608
respectively), but significantly increased (15,174 ± 3,975)
if MSCs were added directly. It can be assumed that the
injured H9c2 cells were washed out during medium
change so only a part of H9c2 cells remained in the wells
(Figure 3C). We also examined the inserts with confocal
microscopy to eliminate the possibility of decreased MSC
viability on the cell culture inserts. MSCs were labeled
with Vybrant DiD before seeding on the cell inserts. We
found that Vybrant DiD labeled MSCs were attached to
the surface of the inserts and showed normal cell mor-
phology (Figure 3D). We also investigated whether any of
the MSCs had contaminated the underlying H9c2 cardio-
myoblast culture, but found no trace of MSCs among the
H9c2 cells; therefore no direct cell-to-cell contact could
be formed (data not shown).
Confocal microscopy and flow cytometry
Development of intercellular connections, so-called nan-
otubes, between cardiomyoblasts and MSCs during the
24 hr period after OGD was frequently observed (Figure
4A). These nanotubes were long enough to span dis-
tances of several cell diameters, and their diameters were
between 200 and 500 nm. MitoTracker Red staining
revealed that these nanotubes connecting stem cells to
cardiomyoblasts contained functionally active mitochon-
dria (Figure 4B). Time lapse video microscopy did notCselenyák et al. BMC Cell Biology 2010, 11:29
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Figure 1 Ischemia model on cardiomyoblasts. (A) Follow up of OGD on cardiomyoblasts. Cells were stained with calcein-AM (ex/em 494/517 nm) 
for live cells (green) and ethidium homodimer (ex/em 528/617 nm) for dead cells (red). (B) Flow cytometry analysis of control and ischemic cardio-
myoblasts labeled with ethidium homodimer after OGD. The green curve represents the control cardiomyoblasts and the red shows the ischemic 
cardiomyoblasts. The complete rightward shift of the red curve based on these representative data indicates that OGD increased the number of dead 
cells nearly maximally.Cselenyák et al. BMC Cell Biology 2010, 11:29
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reveal a specific direction for the movement of these
mitochondria in the intercellular connections and the
typical time frame for the formation of a nanotube was
approximately 2 hours (Figure 4C and additional file 2:
video2.mov).
Addition to the formation of intercellular communica-
tions, double labeled and double nuclei cells indicated
that cell fusion events were present in the co-cultures.
The typical time frame for a cell fusion was approxi-
mately 4 hours (Figure 5 and additional file 3:
video3.mov). To examine whether cell fusion occurs in
Figure 2 Morphology and viability of H9c2 cells 24 hours after OGD. (A) DiO-labeled H9c2 cells without MSCs observed 24 hours after OGD were 
predominantly rounded up and stained with ethidium homodimer indicating cell death in progress. (B) Flow cytometry analysis of control and isch-
emic H9c2 cells cultured for 24 hours after OGD labeled with ethidium homodimer (ex/em 528/617 nm) showed that the number of dead H9c2 cells 
was elevated compared to the control group (median fluorescence from 19 to 65 units). (C) Co-cultivation of DiO-labeled H9c2 (ex/em 488/501 nm) 
cells and DiD-labeled MSCs (ex/em 633/665 nm) for 24 hours after OGD showed that the morphology of ischemically damaged cells were normal 
after 24 hours. (D) Flow cytometry analysis revealed that after co-cultivation of cells the number of dead H9c2 cells remained on the control level (me-
dian fluorescence 24 versus 23 units).Cselenyák et al. BMC Cell Biology 2010, 11:29
http://www.biomedcentral.com/1471-2121/11/29
Page 6 of 11
normal, non-ischemic conditions among H9c2 cells and
MSCs we co-cultured these cells without OGD and found
that such phenomenon also occurs among healthy cells.
Flow cytometry analysis showed beside 59.42% of DiO-
labeled H9c2 cells and 30.1% of DiD-labeled MSCs also
8.14% of double labeled cells. However, according to the
forward and side scatter plot the distribution demon-
strates that most of the double labeled cells are the same
size as H9c2 cells or MSCs, suggesting that these cells are
picking up the other marker through direct cell-to-cell
contact (Figure 6C and 6D).
We also considered the possibility that MSCs may
incorporate cell debris and thus acquire double labeling
of fluorescent dyes. During the observations performed
with time-lapse video microscopy we frequently saw that
healthy cells contacted and moved around cell debris and
apoptotic bodies in the culture dish, however, phagocyto-
sis was not observed. The cells which contacted differen-
tially stained cell debris did not pick up any fluorescent
signal from the other, indicating that the double labeling
of cells arose from a specific and controlled mechanism
rather than cross-contamination. This is further
strengthened by the observation that not all cell-to-cell
connection resulted in dye transfer. (additional file 4:
video4.mov)
Discussion
We report that healthy mesenchymal stem cells are capa-
ble of rescuing post-ischemic cardiomyoblasts from cell
death through a mechanism not yet implicated in the
effects of stem cells after ischemic conditions. Thus, the
beneficial effect of stem cell grafting may be based not
only on improved neovascularisation and replacement of
lost cells but on rescuing the damaged cells of the host as
well.
Figure 3 Co-cultivation of H9c2 cells with MSCs decreased cell death. (A) Experimental layouts after in vitro ischemia. (B) The ratio of dead H9c2 
cells was significantly smaller when MSCs were added after OGD (0.85 ± 0.086 vs. 0.16 ± 0.035, n = 5), but MSCs added in cell culture inserts did not 
decrease significantly the ratio of dead H9c2 cells (0.90 ± 0.055, n = 5). Data represent mean ± SEM. *p < 0.05 C+MSC vs. C and C+MSC vs. C+MSC ins. 
(C: H9c2 cells only; C+MSC: H9c2 cells and MSCs; C+MSC ins: H9c2 cells and MSCs in cell culture inserts) (C) Absolute number of live H9c2 cells before 
and after OGD shows that before OGD the H9c2 cells were close to confluence (63,120 ± 7,694) and there was little increase in cell numbers during 
the next 24 hours if the cells were left to grow without OGD (76,116 ± 3,396). 24 hours after OGD the number of viable cells was very low when cultured 
alone or with MSCs in cell insert (1,757 ± 1,081 and 990 ± 608 respectively), which was significantly increased (15,174 ± 3,975) if MSCs added directly. 
(D) MSCs labeled with Vybrant DiD were growing on cell culture inserts in the same manner as under normal culture conditions after 24 hours of 
cultivation. Scale bar represents 100 μm.Cselenyák et al. BMC Cell Biology 2010, 11:29
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The most likely explanation of the beneficial effects of
MSC co-culture is that these cells improve the chances of
the damaged H9c2 cells to restore their function and pre-
vent later cell death. Ethidium homodimer has been
shown to stain not only dead but damaged cells as well
[23]. Thus, although most H9c2 cells were stained by
ethidium homodimer after OGD (Figure 1B), many cells
were probably only reversibly damaged. An alternative
explanation of our results could be an increased replica-
tion of surviving H9c2 cells. However, the nearly ten-fold
difference in the number of viable H9c2 cells between our
experimental groups 24 hr after OGD (Figure 3C) and the
normal doubling time of these cells make this possibility
unlikely to explain the difference.
The used in vitro ischemia model demonstrates that the
beneficial effects of MSC co-culture seem to be depen-
dent on direct cell-to-cell connections and intercellular
nanotubes.
Nanotube formation has already been shown to occur
among endothelial progenitor cells, cardiomyocytes
[20,24], immune cells and other lineages [25,26]. The
characterization of nanotubes revealed that these fila-
ments contain actin and in some cases, microsomes or
mitochondria [27]. We found that this phenomenon
occurs frequently between cardiomyoblasts and mesen-
chymal stem cells. Stem cells failed to rescue post-isch-
emic cardiomyoblasts when intercellular connections
were blocked by a physical barrier. These observations
indicate that intercellular connections work toward the
survival of cells both during and after ischemia, however,
the underlying mechanisms may be slightly different.
One plausible mechanism for the rescuing effect is that
transplanted cells improve regeneration through secret-
ing paracrine factors [14,28-31]. However, results from
our experiments with the plate insert show that paracrine
factors secreted by the cells are probably too low in our
Figure 4 Formation of intercellular connections after OGD. (A) Nanotubular network formation was observed among DiO-labeled cardiomyo-
blasts (green) and DiD-labeled MSCs (red) after 24 hours of co-culture. (B) MitoTracker staining (red) revealed active mitochondria in the nanotubular 
network (yellow arrows). (C) Time lapse pictures of the formation of a nanotube between a DiO-labeled cardiomyoblast (green) and DiD-labeled stem 
cell (red).Cselenyák et al. BMC Cell Biology 2010, 11:29
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system to have any beneficial effect on these severely
damaged cells. This in vitro experimental setup allows
the investigation of cell-to-cell contacts, however, it can-
not rule out that paracrine effects play a significant role in
a more physiological in vivo setting. The time frame of
the experimental protocol is also important. In our exper-
iments we added the cells at an early time point and ter-
minated the experiment before significant differentiation
can occur. During a later time point the effect of para-
crine factors is probably much more important especially
in the differentiation process as shown by several other
authors [6,11].
Cell fusion is another phenomenon which is frequently
observed in co-culture studies and in some cases, in in
vivo experiments as well [15,32,33]. Several studies have
shown that cell fusion can result in transdifferentiation,
thus offering an alternative mechanism by which grafted
cells improve the infarcted myocardium. Using videomi-
croscopy we also found several double labeled, double
nuclei cells indicative of cell fusion. However, cell fusion
showed high variations among different culture and
detection techniques, and therefore extensive cell fusion
as an in vitro artefact cannot be ruled out [14,34,35]. Dur-
ing our investigations we only observed a few unques-
tionable cell fusions which cannot account for the rescue
of the high number of damaged cardiomyoblasts [36].
We also found double labeled cells without double
nuclei in the co-culture of cardiomyoblasts and stem cells
after 24 hours. The double labeling of these cells may be
the result of direct cell-to cell connections. During these
periods of connection, cells are able to exchange mem-
brane parts and Vybrant dye molecules can drift from
one cell to another. Movement of dye molecules from one
cell to another through gap junction connections is pre-
cluded because the lipophilic Vybrant dyes are high
molecular weight stains and cannot permeate through
gap junctions [34]. Driesen et al. [19] showed that low
molecular weight tracers such as calcein-AM get from
one cell to another through gap junctions, and high
molecular weight tracers by partial cell fusion, thus the
conclusion may be drawn that dye transfers after 24 hours
in our experiment are most probably the results of direct
cell-to-cell connections. Still, gap junctions may create an
opportunity for grafted cells to interact with the host tis-
sues [37,38]. In the present experimental model most of
cell-to-cell interactions were short-lived tubular connec-
tions, which formed a constantly changing web between
the two investigated cell types.
Figure 5 Cell fusion of a H9c2 cell and a mesenchymal stem cell. The time lapse pictures demonstrate steps of the fusion of a H9c2 cell (green) 
and a mesenchymal stem cell (red). Fused cells with double nuclei exhibit a combined yellow staining.Cselenyák et al. BMC Cell Biology 2010, 11:29
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Our experimental model was devised to investigate
acute effects with high temporal and spatial resolution,
therefore ruling out differentiation, which occurs over
time. Moreover, an in vitro transplantation model in a cell
culture system cannot mimic the 3-dimensional tissue
where cell-to-cell connections are different. These cir-
cumstances obviously limit the conclusions drawn from
our results. On the other hand, this experimental setting
was necessary and favorable to investigate short-term cel-
lular interactions.
Conclusions
The present study highlights that stem cell grafting may
be beneficial through an acute, direct mechanism which
saves damaged cardiomyoblasts. Novel grafting protocols
can harness this effect, which raises the possibility that
Figure 6 Co-culture of H9c2 and stem cells in normal conditions. (A) Cardiomyoblasts (green) and MSCs (red) after one day co-cultivation. (B) A 
representative double labeled cell with double nuclei (nuclei were stained with Hoechst). (C) DiO-labeled cardiomyoblasts (green) and DiD-labeled 
MSCs (red) analyzed with flow cytometry after one day co-cultivation. We found three different cell populations: 59.42% of DiO-labeled H9c2 cells, 
30.1% of DiD-labeled MSCs and 8.14% of double labeled cells. (D) The distribution according to the forward scatter plot demonstrates that several 
double labeled yellow cells are mostly the same size as the green H9c2 cells or the red MSCs disapproving complete cell fusion.Cselenyák et al. BMC Cell Biology 2010, 11:29
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stem cells given early and locally can preserve heart tissue
rather than simply help to replace what is already lost.
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